Home » Lexicon Reports Positive Result From Phase II Study
Lexicon Reports Positive Result From Phase II Study
Lexicon Pharmaceuticals Inc. said Wednesday that it obtained positive results from
a recently completed Phase 2 study of its LX4211 drug in patients with type 2 diabetes mellitus.
MarketWatch
MarketWatch
Upcoming Events
-
07May
-
14May
-
30May